Travere Therapeutics (TVTX) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.97% |
| Dec 31, 2025 | 1.88% |
| Sep 30, 2025 | -11.16% |
| Jun 30, 2025 | -20.53% |
| Mar 31, 2025 | -1.58% |
| Dec 31, 2024 | -1.28% |
| Sep 30, 2024 | -11.00% |
| Jun 30, 2024 | -15.66% |
| Mar 31, 2024 | -9.14% |
| Dec 31, 2023 | -10.77% |
| Sep 30, 2023 | -1.41% |
| Jun 30, 2023 | -4.52% |
| Mar 31, 2023 | 21.43% |
| Dec 31, 2022 | -9.10% |
| Sep 30, 2022 | 8.86% |
| Jun 30, 2022 | 15.03% |
| Mar 31, 2022 | 43.70% |
| Dec 31, 2021 | 32.23% |
| Sep 30, 2021 | 44.46% |
| Jun 30, 2021 | 31.53% |
| Mar 31, 2021 | 44.83% |
| Dec 31, 2020 | 17.53% |
| Sep 30, 2020 | 7.35% |
| Jun 30, 2020 | 13.17% |
| Mar 31, 2020 | -11.02% |
| Dec 31, 2019 | 27.95% |
| Sep 30, 2019 | 20.31% |
| Jun 30, 2019 | 13.66% |
| Mar 31, 2019 | 80.01% |
| Dec 31, 2018 | 76.55% |
| Sep 30, 2018 | 63.11% |